189 results
Page 6 of 10
6-K
EX-99.1
nqxct0zqrswdbsrn
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
6-K
EX-99.1
73wsa
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.2
5c8be rxse6rno2fab1
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
cdiyc4onqahf64
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.1
r7tqlptc7jnw4 zzg4ub
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.5
17wp880itw9yxi2bt
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
disyzf ylndm4o
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
8vf7p
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.3
adak46yl79fckawsprse
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.2
ktu879anctry9n
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
g7l7mb c1cd7e
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
jwgoq
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
2hipp who
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
lv3a u93ivur
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
xvvrlov4j6 r8fdv3
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
8zosici92ye57hs
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
lpnv15iq4kp
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
wax9dce zw
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
couzu0k6utdu 1h7is6q
26 Mar 19
Current report (foreign)
1:45pm